Stone House Investment Management’s Editas Medicine EDIT Stock Holding History

Stone House Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47K	Hold	1,000	–	–	﹤0.01%	564
2025 Q4	$2.05K	Hold	1,000	–	–	﹤0.01%	553
2025 Q3	$3.47K	Hold	1,000	–	–	﹤0.01%	415
2025 Q2	$2.2K	Hold	1,000	–	–	﹤0.01%	405
2025 Q1	$1.16K	Buy	+1,000	New	+$1.47K	﹤0.01%	404
2024 Q4	–	Sell	-1,062	Closed	-$3.62K	–	148
2024 Q3	$3.62K	Hold	1,062	–	–	﹤0.01%	300
2024 Q2	$4.96K	Hold	1,062	–	–	﹤0.01%	274
2024 Q1	$7.88K	Hold	1,062	–	–	﹤0.01%	250
2023 Q4	$10.8K	Hold	1,062	–	–	﹤0.01%	158
2023 Q3	$8.28K	Hold	1,062	–	–	﹤0.01%	174
2023 Q2	$8.74K	Hold	1,062	–	–	﹤0.01%	171
2023 Q1	$7.7K	Buy	+1,062	New	+$9.44K	﹤0.01%	180
2019 Q2	–	Sell	-1,000	Closed	-$24K	–	76
2019 Q1	$24K	Buy	+1,000	New	+$22.6K	0.01%	127

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stone House Investment Management's EDIT Position: Q1 2026 in Review

Stone House Investment Management held its Editas Medicine (EDIT) position steady in Q1 2026 at 1,000 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Stone House Investment Management first reported a position in EDIT in Q1 2019 and has held it in 13 quarters since. The position peaked at $24K in Q1 2019. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Stone House Investment Management held 1,000 shares of Editas Medicine worth $2.47K as of Q1 2026.
Stone House Investment Management left its Editas Medicine share count unchanged in Q1 2026.
Editas Medicine made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #564 holding.
Stone House Investment Management first reported a position in Editas Medicine in Q1 2019 and has held it in 13 quarters since.
Stone House Investment Management's Editas Medicine position peaked at $24K in Q1 2019.
207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.